Physical and psychological symptoms of quality of life in the CHART randomized trial in head and neck cancer: short-term and long-term patient reported symptoms. CHART Steering Committee. Continuous hyperfractionated accelerated radiotherapy
Physical and psychological symptoms of quality of life in the CHART randomized trial in head and neck cancer: short-term and long-term patient reported symptoms. CHART Steering Committee. Continuous hyperfractionated accelerated radiotherapy
The randomized multicentre trial of continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in patients with advanced head and neck cancer showed no good evidence of a difference in any of the major clinical outcomes of survival, freedom from metastases, loco-regional control and disease-free survival. Therefore an assessment of the effect of treatment on physical and psychological symptoms is vital to balance the costs and benefits of the two treatments. A total of 615 patients were asked to complete a Rotterdam Symptom Checklist and the Hospital Anxiety and Depression Scale, which cover a variety of physical and psychological symptoms, at a total of ten time points. The data consisted of short-term data (the initial 3 months) and long-term data (1 and 2 years). The short-term data was split into an exploratory data set and a confirmatory data set, and analysed using subject-specific and group-based methods. Differences were only claimed if hypotheses generated in the exploratory data set were confirmed in the confirmatory data set. The long-term data was not split into two data sets and was analysed using a group-based approach. There was evidence of significantly worse symptoms of pain at day 21 in those treated with CHART and significantly worse symptoms of cough and hoarseness at 6 weeks in those treated conventionally. There was also evidence to suggest a higher degree of decreased sexual interest at 1 year and sore muscles at 2 years in those treated with conventional radiotherapy. There is no clear indication that one regimen is superior to the other in terms of 'quality of life', generally the initially more severe reaction in the CHART group being offset by the longer duration of symptoms in the conventionally treated group.
Anxiety, Depression, Disease-Free Survival, Head and Neck Neoplasms, Humans, Quality of Life, Time Factors, Treatment Outcome, Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
1196-1205
Griffiths, G.O.
7fd300c0-d279-4ff6-842d-aa1f2b9b864d
Parmar, M.K.B.
44634dd0-3f2b-4263-9f16-308a9e9260b8
Bailey, A.J.
d2fa1585-5cc9-4807-b4d2-d8f60b90a6f2
December 1999
Griffiths, G.O.
7fd300c0-d279-4ff6-842d-aa1f2b9b864d
Parmar, M.K.B.
44634dd0-3f2b-4263-9f16-308a9e9260b8
Bailey, A.J.
d2fa1585-5cc9-4807-b4d2-d8f60b90a6f2
CHART Steering Group
(1999)
Physical and psychological symptoms of quality of life in the CHART randomized trial in head and neck cancer: short-term and long-term patient reported symptoms. CHART Steering Committee. Continuous hyperfractionated accelerated radiotherapy.
British Journal of Cancer, 81 (7), .
(doi:10.1038/sj.bjc.6690829).
Abstract
The randomized multicentre trial of continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in patients with advanced head and neck cancer showed no good evidence of a difference in any of the major clinical outcomes of survival, freedom from metastases, loco-regional control and disease-free survival. Therefore an assessment of the effect of treatment on physical and psychological symptoms is vital to balance the costs and benefits of the two treatments. A total of 615 patients were asked to complete a Rotterdam Symptom Checklist and the Hospital Anxiety and Depression Scale, which cover a variety of physical and psychological symptoms, at a total of ten time points. The data consisted of short-term data (the initial 3 months) and long-term data (1 and 2 years). The short-term data was split into an exploratory data set and a confirmatory data set, and analysed using subject-specific and group-based methods. Differences were only claimed if hypotheses generated in the exploratory data set were confirmed in the confirmatory data set. The long-term data was not split into two data sets and was analysed using a group-based approach. There was evidence of significantly worse symptoms of pain at day 21 in those treated with CHART and significantly worse symptoms of cough and hoarseness at 6 weeks in those treated conventionally. There was also evidence to suggest a higher degree of decreased sexual interest at 1 year and sore muscles at 2 years in those treated with conventional radiotherapy. There is no clear indication that one regimen is superior to the other in terms of 'quality of life', generally the initially more severe reaction in the CHART group being offset by the longer duration of symptoms in the conventionally treated group.
This record has no associated files available for download.
More information
Published date: December 1999
Keywords:
Anxiety, Depression, Disease-Free Survival, Head and Neck Neoplasms, Humans, Quality of Life, Time Factors, Treatment Outcome, Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
Organisations:
Clinical Trials Unit
Identifiers
Local EPrints ID: 406313
URI: http://eprints.soton.ac.uk/id/eprint/406313
ISSN: 0007-0920
PURE UUID: ee091e0c-a15c-4f65-924f-b10caba1012f
Catalogue record
Date deposited: 10 Mar 2017 10:44
Last modified: 16 Mar 2024 04:19
Export record
Altmetrics
Contributors
Author:
M.K.B. Parmar
Author:
A.J. Bailey
Corporate Author: CHART Steering Group
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics